10 Alnylam regulatory affairs leaders
Andrew Slugg, Senior Vice President, Head of Global Regulatory Affairs, is the most senior of these Alnylam regulatory affairs leaders, whose current titles also cover regulatory CMC and US advertising and promotion. A reader can learn how regulatory affairs leaders work at Alnylam from people who have held the role.
Professionals to explore
Andrew Slugg
LinkedInExperience: Senior Vice President, Head of Global Regulatory Affairs · Alnylam Pharmaceuticals
Andrew Slugg has been Senior Vice President, Head of Global Regulatory Affairs at Alnylam Pharmaceuticals since July 2016, based in Greater Boston. Andrew Slugg was Vice President, Regulatory Affairs at ARIAD Pharmaceuticals, Inc. from 2011 to 2016 and Director, Regulatory Affairs at Ipsen from 2005 to 2011.
Arwa El Hagrasy
LinkedInExperience: Director, Regulatory Affairs CMC · Alnylam Pharmaceuticals
Arwa El Hagrasy has been Director, Regulatory Affairs CMC at Alnylam Pharmaceuticals since February 2023, based in the Washington DC-Baltimore Area. Arwa El Hagrasy was Associate Director, Regulatory Affairs at Alnylam from 2021 to 2023 and Senior Chemist Quality Assessment Lead (Acting) at FDA from 2016 to 2021.
Benjamin Stevens
LinkedInExperience: Senior Director, Regulatory Affairs CMC Policy and Advocacy · Alnylam Pharmaceuticals
Benjamin Stevens has been Senior Director, Regulatory Affairs CMC Policy and Advocacy at Alnylam Pharmaceuticals since January 2026, based in Phoenixville, Pennsylvania. Benjamin Stevens was Director CMC Policy and Advocacy at GSK from 2021 to 2025 and Senior Director CMC Policy and Advocacy there from December 2025 to January 2026, and was Director Regulatory Affairs CMC at Alnylam from 2020 to 2021.
Bridget Rothwell, PharmD, RPh
LinkedInExperience: Director | Regulatory Affairs · Alnylam Pharmaceuticals
Bridget Rothwell has been Director | Regulatory Affairs at Alnylam Pharmaceuticals since March 2024, based in Boston. Bridget Rothwell was Associate Director | Regulatory Affairs at Alnylam from 2021 to 2024 and Global Regulatory Affairs Team Lead at Sanofi from 2018 to 2021.
Debi Nhu Tran
LinkedInExperience: Vice President Regulatory Affairs · Alnylam Pharmaceuticals
Debi Nhu Tran has been Vice President Regulatory Affairs at Alnylam Pharmaceuticals since January 2023, based in Philadelphia, and the profile headline reads VP, Head of Regulatory Strategy, Ad/Promo @ Alnylam. Debi Nhu Tran was Senior Director Regulatory Affairs at Alnylam from 2019 to 2023 and Director Global Regulatory Lead at Pfizer from 2008 to 2019.
Helene Brough
LinkedInExperience: Senior Director Regulatory Affairs, CMC · Alnylam Pharmaceuticals
Helene Brough has been Senior Director Regulatory Affairs, CMC at Alnylam Pharmaceuticals since February 2017, based in Boston, and the profile headline reads Senior Director Regulatory Science CMC at Alnylam Pharmaceuticals. At Shire, Helene Brough was Associate Director, Manufacturing Science and Technology from 2015 to 2017 and Manager, Global Regulatory Affairs, CMC from 2011 to 2013.
Holly Maier
LinkedInExperience: Senior Director, Regulatory Affairs · Alnylam Pharmaceuticals
Holly Maier has been Senior Director, Regulatory Affairs at Alnylam Pharmaceuticals since August 2023, based in Arlington, Massachusetts. At Alnylam, Holly Maier was Director, Regulatory Affairs from 2019 to 2023 and Associate Director, Regulatory Affairs from 2017 to 2019, and was Associate Director, Regulatory Affairs at Biogen from 2015 to 2016.
Jennifer Lynn Backo
LinkedInExperience: Senior Director, US Advertising & Promotion, Regulatory Affairs · Alnylam Pharmaceuticals
Jennifer Lynn Backo has been Senior Director, US Advertising & Promotion, Regulatory Affairs at Alnylam Pharmaceuticals since September 2025, based in Greater Boston. At Alnylam, Jennifer Lynn Backo was Director, US Advertising & Promotion, Regulatory Affairs from 2020 to 2025 and Associate Director in the same area from 2018 to 2020, and held that Associate Director title at Shire from 2017 to 2018.
Natacha Miller
LinkedInExperience: Former Director Regulatory Affairs, Global Labeling · Alnylam Pharmaceuticals
Natacha Miller was Director Regulatory Affairs, Global Labeling at Alnylam Pharmaceuticals from July 2021 to March 2026, based in Middleton, Massachusetts. Natacha Miller was Associate Director RA at Shire from 2015 to 2017 and has held a regulatory affairs and global labeling strategy role at Lundbeck since April 2026.
Samuel Rigourd
LinkedInExperience: Senior Director Regulatory Affairs · Alnylam Pharmaceuticals
Samuel Rigourd has been Senior Director Regulatory Affairs at Alnylam Pharmaceuticals since December 2016 and has also been Executive Director there since October 2025, based in Boston. Samuel Rigourd was Global Program Regulatory Director - NIBR at Alcon from 2014 to 2016 and Global Program Regulatory Director at Novartis from 2012 to 2014.
Choose the right perspective
Match the scope in a person's title, such as global regulatory affairs, regulatory CMC or advertising and promotion, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Alnylam?
- 02How do you divide regulatory work between global strategy and CMC in your own role?
- 03What has your own work at Alnylam taught you about building a regulatory affairs function?
Reaching Alnylam regulatory affairs leaders
How can I contact one of these Alnylam regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Alnylam Pharmaceuticals, based on profile data retrieved on October 25, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Alnylam regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Alnylam regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.